Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Toni Choueiri, MD, discusses the use of checkpoint inhibitors to treat patients with sarcomatoid carcinoma.

Dr. Choueiri on Checkpoint Inhibitors to Treat Sarcomatoid Carcinoma

Jyoti Malhotra, MD, MPH, discusses a phase I multicenter trial of PD-1 blockade with pembrolizumab with concurrent chemoradiation in patients with locally advanced, unresectable non–small cell lung cancer.

Dr. Malhotra on Pembrolizumab During Concurrent Chemoradiation in NSCLC

Investigators see potential in adding targeted therapy to dual immunotherapy for intermediate- and poor-risk patients with renal cell carcinoma. In the phase III COSMIC-313 trial, investigators aim to evaluate cabozantinib, nivolumab, and ipilimumab in patients with untreated advanced RCC.

Trial of Triplet Regimen With Cabozantinib Plus Immunotherapy Is Planned in RCC

Timothy M. Kuzel, MD, FACP, discusses the use of immunotherapy as a targeted approach to treating cancer.

Dr. Kuzel on Immunotherapy as a Targeted Approach to Cancer

Switch maintenance treatment with pembrolizumab improved progression-free survival in patients with metastatic urothelial cancer who have stable disease following frontline platinum-based chemotherapy.

Maintenance Pembrolizumab Extends PFS in Metastatic Urothelial Cancer

Immunotherapy in Lung Cancer

SCLC: Clinical Trials of Interest Using Novel Approaches

IMpower133 in SCLC

Treating Progressive Cases of Metastatic NSCLC

TMB and Immunotherapy in Advanced NSCLC

Maintenance Therapy for Advanced Nonsquamous NSCLC

Pemetrexed for Advanced NSCLC

Antiangiogenic Therapy in Advanced NSCLC

The KEYNOTE-407 Trial in Metastatic Squamous NSCLC

Approaching Non-Driver Stage IV NSCLC

Immunotherapy in Early Stage NSCLC

Immunotherapy in Stage III NSCLC

Reactions to the PACIFIC Trial in Stage III NSCLC

Locally Advanced NSCLC and Treatment Decisions

Locally Advanced NSCLC: Staging and Diagnosis

Immuno-Oncology

Immuno-Oncology | Specialty